Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS MSCI Switzerland hEUR ETF EUR dis
CH0226274204 · CH0226274204 · EUR · domicile Switzerland
EquityEUR-hedged share classSFDR art. 6
Index tracked: MSCI Switzerland 100% hedged to EUR Total Return Net
- TER
- 0.23%+ trans. 0.12%
- Fund size
- —
- Tracking difference
- −0.17%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Distributingmonthly
Launch 31 Oct 2013 · costs from the KID as of 26 Aug 2026 · 2 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
The investment objective of the subfund is to track the price and income performance before costs of the MSCI Switzerland 100% hedged to EUR (Net Return). This subfund invests in shares of companies that are included in the MSCI Switzerland 100% hedged to EUR (Net Return) and in shares that are not represented in the MSCI Switzerland 100% hedged to EUR (Net Return) but which have been announced to be included in the MSCI Switzerland 100% hedged to EUR (Net Return) and other investments permitted under the fund contract. In principle, the performance of…
Performance since series start (in euro) — base 100
31 Oct 2013 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +17.5% |
| 3 years | +43.3% |
| 5 years | +29.5% |
| 10 years | +119.8% |
| Since series start | +142.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.70% | 12.71% | 13.56% |
| Max drawdown | −11.61% | −16.98% | −23.59% |
| Sharpe | 1.21 | 0.64 | 0.14 |
| Sortino | 1.77 | 0.85 | 0.19 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CH0226274204 · CH02262742041
RebalixCH0226274204 · CH0226274204 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +19.25% | +19.30% | −0.06% |
| 2024 | +8.20% | +8.31% | −0.12% |
| 2023 | +7.26% | +7.57% | −0.32% |
| 2022 | −17.12% | −16.87% | −0.25% |
| 2021 | +23.17% | +23.37% | −0.19% |
Distributions · per share, in EUR
Frequency: monthly · last 12 months: 0.2795 EUR (0.83% of NAV) · last ex-date 20 Apr 2026
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.2795 | — |
| 2025 | 3 | 0.5315 | +2.00% |
| 2024 | 1 | 0.4955 | +1.98% |
| 2023 | 1 | 0.4725 | +1.99% |
| 2022 | 1 | 0.4205 | +1.44% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
UFU7 · Börse Hannover, Tradegate Exchange
+ 2 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/CH0226274204
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/CH0226274204
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CH0226274204 · CH02262742042